These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11985086)

  • 1. [History of cardiology in the last 100 years: Heart and vasoactive substances].
    Kinoshita M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91(3):828-31. PubMed ID: 11985086
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of RAS block in heart diseases].
    Saito Y
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1750-5. PubMed ID: 17037310
    [No Abstract]   [Full Text] [Related]  

  • 3. Slowing the progression of CHF. Drug therapy to correct neurohormonal abnormalities.
    Ward RP; Anderson AS
    Postgrad Med; 2001 Mar; 109(3):36-8, 41-5. PubMed ID: 11265361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug treatment of heart failure--what's new after the era of angiotensin converting enzyme inhibitors].
    Gierlotka M; Adamowicz-Czoch E
    Pol Arch Med Wewn; 1999 Mar; 101(3):259-67. PubMed ID: 10697405
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasopeptidase inhibition: a new pharmacological principle in the treatment of hypertension and cardiac insufficiency].
    Kolloch R; Offers E
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1342-7. PubMed ID: 11719860
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic management of heart failure: neurohormonal agents.
    Moser DK
    Crit Care Nurs Clin North Am; 1993 Dec; 5(4):599-608. PubMed ID: 7905275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 9. [Natriuretic peptides in patients with heart failure].
    Horii M; Saito Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():84-7. PubMed ID: 15506343
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs for chronic heart failure.
    Med Lett Drugs Ther; 2015 Jan; 57(1460):9-13. PubMed ID: 25581106
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of ACE inhibitors and atrial natriuretic factor on the cardiorenal axis in man.
    Struthers AD
    Br J Clin Pharmacol; 1992 Jul; 34(1):21-4. PubMed ID: 1385970
    [No Abstract]   [Full Text] [Related]  

  • 12. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
    Cohn JN
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):137-9. PubMed ID: 14608516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of sodium and water retention in heart failure.
    Cadnapaphornchai MA; Gurevich AK; Weinberger HD; Schrier RW
    Cardiology; 2001; 96(3-4):122-31. PubMed ID: 11805379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormones and hemodynamics in heart failure.
    Schrier RW; Abraham WT
    N Engl J Med; 1999 Aug; 341(8):577-85. PubMed ID: 10451464
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neurohormonal mechanisms in congestive heart failure].
    Goch JH
    Pol Arch Med Wewn; 1992; 88(2-3):171-4. PubMed ID: 1492022
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
    Kubota T; Takeshita A
    Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crunch time for heart failure care in England and Wales.
    Lancet; 2010 Dec; 376(9758):2041. PubMed ID: 21168037
    [No Abstract]   [Full Text] [Related]  

  • 19. The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.
    Liu P; Arnold JM; Belenkie I; Demers C; Dorian P; Gianetti N; Haddad H; Howlett J; Ignazewski A; Jong P; McKelvie R; Moe G; Parker JD; Rao V; Rouleau JL; Teo K; Tsuyuki R; White M; Huckel V; Issac D; Johnstone D; LeBlanc MH; Lee H; Newton G; Niznick J; Ross H; Roth S; Roy D; Smith S; Sussex B; Yusuf S;
    Can J Cardiol; 2003 Mar; 19(4):347-56. PubMed ID: 12704478
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapies following heart failure and myocardial infarction(discussion)].
    Shimizu T; Komuro I; Hirayama H; Hiramitsu S; Shimizu K; Yoshida O
    Nihon Rinsho; 2002 Jun; 60(6):1235-50. PubMed ID: 12143782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.